Irish contract research organization ICON (Nasdaq: ICON) has retained its position as the most active CRO worldwide in the ...

Two executives with ties to President Donald Trump and Trump Media & Technology Group (NASDAQ:DJT) have a new SPAC offering ...

Market turmoil may have frozen the traditional IPO pipeline, but German antibody biotech Veraxa is turning to the special purpose acquisition company (SPAC) model to hop onto the Nasdaq.

Swiss biotech investor Xlife Sciences AG said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S. exchange Nasdaq in a $1.64 billion merger deal with a special-purpose acquisition ...

ICON Public Limited Company (NASDAQ:ICLR) received a lot of attention from a substantial price movement on the NASDAQGS over the last few months, increasing to US$218 at one point, and dropping to ...

Zurich-based start-up Veraxa Biotech has reached a deal to merge with special purpose acquisition company (SPAC) Voyager, gaining a listing on the Nasdaq that will give it a valuation of around $1 ...